Data

(Image: Getty/Utah778)

Shyft Analytics bolsters RWE solutions

By Melissa Fassbender

Medidata’s Shyft expands its real-world data services to meet the various real-world evidence needs of its customer’s organizations, says new VP.

(Image: Getty/ipopba)

AI threatens health data privacy: Report

By Melissa Fassbender

Artificial intelligence advances threaten data privacy, according to a new study, which found it is possible to re-identify individuals using their physical activity data.

(Image: Getty/Natali_Mis)

Digital tech exploded in 2018: Will 2019 see broad adoption?

By Melissa Fassbender

Awareness around the potential opportunities created by artificial intelligence has never been higher, but pharma’s biggest challenge in 2019 will be adopting and scaling the right technology to improve patient outcomes, says an industry executive.

(Image: Getty/masterzphotois)

The biggest paradigm shift in decades? ICH E6 R2

By Melissa Fassbender

ICH E6 R2 sparked a paradigm shift, though 2019 will see the clinical trials industry transition from a risk-based monitoring approach to risk-based quality management.

(Image: Getty/utah778)

GSK taps TrialScope for clinical trial transparency

By Melissa Fassbender

GlaxoSmithKline has selected TrialScope to facilitate clinical trial disclosure and transparency – as the benefits of patient centricity are paramount, and the risks of poor compliance magnified, says VP.

iStock/mjbs

DSG opens new office in India

By Melissa Fassbender

DSG, Inc. has opened a new office in Bangalore, India as it looks to increase efficiency and enhance its data management capabilities.

Akebia signs up Quintiles for Phase III study

Akebia signs up Quintiles for Phase III study

By Zachary Brennan

Akebia Therapeutics has signed a master services agreement with CRO Quintiles in connection with its planned Phase III studies for Akebia’s lead product candidate for the treatment of anemia secondary to chronic kidney disease in non-dialysis patients. 

AniClin partners for PK

AniClin partners for PK

AniClin Preclinical Services has formed a strategic alliance with Taylor Technology, a subsidiary of PharmaNet, to offer clients complete pharmacokinetic (PK) studies in fewer than five days.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All